Effects of Toll-like receptor 1 and 2 agonist Pam3CSK4 on uveal melanocytes and relevant experimental mouse model

Dan-Ning Hu1, Ruihua Zhang2, Codrin E Iacob1

  • 1New York Eye and Ear Infirmary of Mount Sinai, New York, NY, USA; Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Experimental Eye Research
|December 19, 2023
PubMed

Insights

Pam3CSK4 activates Toll-like receptors 1/2 (TLR1/2) in human uveal melanocytes, leading to increased production of IL-6, MCP-1, CXCL-1, and CXCL-8. Inhibiting TLR2 may offer a therapeutic strategy for ocular inflammatory diseases like uveitis.

Area of Science:

  • Immunology
  • Ophthalmology

Background:

  • Toll-like receptors 1 and 2 (TLR1/2) recognize gram-positive bacterial components.
  • Uveal melanocytes (UM) play a role in ocular inflammation, but their response to TLR agonists is not fully understood.
  • Cytokines like IL-6 and chemokines are implicated in uveitis pathogenesis.

Purpose of the Study:

  • To investigate the effect of Pam3CSK4 on cytokine and chemokine expression in cultured human UM.
  • To elucidate the signaling pathways (MAPK, NF-κB) involved in Pam3CSK4-induced responses.
  • To evaluate the role of TLR2 in a mouse model of Pam3CSK4-induced uveitis.

Main Methods:

  • Human UM cultures were treated with Pam3CSK4.
  • Flow cytometry assessed TLR1/2 expression and MAPK/NF-κB activation.
  • ELISA and Real-time PCR measured cytokine/chemokine levels.
  • TLR2 knockout mice were used to model Pam3CSK4-induced uveitis.

Main Results:

  • Pam3CSK4 upregulated TLR1/2 expression in UM.
  • Significant increases in IL-6, MCP-1, CXCL-1, and CXCL-8 were observed.
  • Pam3CSK4 activated NF-κB, ERK, JNK, and p38 signaling pathways.
  • Pam3CSK4-induced IL-6 production was dependent on NF-κB, ERK, JNK, and p38.
  • Pam3CSK4 induced uveitis in mice, which was attenuated in TLR2 knockout mice.

Conclusions:

  • Human UM respond to Pam3CSK4 by producing pro-inflammatory cytokines and chemokines via TLR1/2 activation and downstream signaling.
  • TLR2 plays a critical role in Pam3CSK4-induced experimental uveitis.
  • Targeting TLR2 may be a potential therapeutic strategy for ocular inflammatory conditions.

Related Concept Videos